Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Renal epithelial cells are the specialized cells that line the nephrons and collecting ducts of the kidney, serving as the primary functional units for blood filtration and urine formation. They play a vital role in maintaining systemic homeostasis by selectively reabsorbing water, electrolytes, and nutrients while actively secreting metabolic waste products and toxins (StatPearls, 2023). These cells are highly heterogeneous, with distinct morphological and functional characteristics depending on their location, such as the proximal tubule, the loop of Henle, or the distal tubule (NIH, 2022). In clinical pathology, renal epithelial cells are central to the development of acute kidney injury (AKI) and chronic kidney disease (CKD), where they may undergo apoptosis or maladaptive phenotypic changes like epithelial-to-mesenchymal transition (Nature Reviews Nephrology, 2020). While the cells themselves are not a single molecular target, they express a wide array of proteins—including the sodium-glucose cotransporter 2 (SGLT2) and various ion channels—that are the actual targets for major drug classes like diuretics and antidiabetics. Consequently, these cells are both the site of therapeutic intervention and a major focus for assessing drug-induced nephrotoxicity during pharmaceutical development.
Renal epithelial cells are not a single molecular target; rather, they are a cell type containing various receptors, transporters, and enzymes (e.g., SGLT2, NKCC2, ACE) that serve as specific therapeutic targets for drugs regulating blood pressure, glucose levels, and fluid balance.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Renal epithelial cell.